What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Galecto Biotech secures €79m in Series C funding to advance idiopathic pulmonary fibrosis treatment Galecto Biotech, a Denmark-based pharmaceutical company specializing in galectin modulators for severe diseases like idiopathic pulmonary fibrosis (IPF)… bypharmanewsdailyOctober 27, 2018